Diphenoxylate Hydrochloride And Atropine Sulfate Tablet
Product Images NDC 75826-107

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Diphenoxylate Hydrochloride And Atropine Sulfate (NDC 75826-107). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Winder Laboratories Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Diphenoxylate 01)

FDA Label Image

Chemical Structure (Diphenoxylate 02)

FDA Label Image

Diphenoxylate 1000ct Rev 05 21

This is a medication containing Diphenoxylate Hydrochloride and Atropine Sulfate available in tablet form. It is habit-forming and should be used only as directed by a doctor. It is cautioned to store below 25°C (77°F) in a well-closed, light-resistant, child-resistant container. The packaging contains 1000 tablets, and each tablet contains 2.5 mg of Diphenoxylate Hydrochloride USP and 0.025 mg of Atropine Sulfate USP. The medication is not recommended for children under six years of age. The manufacturer is Winder Laboratories, LLC located in Georgia.*

FDA Label Image

Diphenoxylate 100ct Rev 01 22

FDA Label Image

Diphenoxylate 10ct Rev 05 21

This is a pharmaceutical product containing diphenoxylate hydrochloride and atropine sulfate USP for oral administration. It is advised to store the product in a cool and dry place below 25°C (77°F). The product should be kept out of reach from children and dispensed in a well-closed, light-resistant, and child-resistant container. The dosage and usage of the product are mentioned in accompanying prescribing information. The product may be habit-forming and should not be prescribed to children under six years of age.*

FDA Label Image

Diphenoxylate 30ct Rev 01 22

This is a medication warning label for Diphenoxylate Hydrochloride and Atropine Sulfate Tablets. Patients are cautioned to store the tablets below 25°C (77°F) in a well-closed, light-resistant, child-resistant container and not to exceed the recommended dose. The tablets may be habit-forming and caution must be taken to keep them out of reach of children. The label also states that the tablets should not be given to children under 6 years of age. Further information and dosage instructions can be found in the accompanying prescribing information. The manufacturer is Winder Laboratories, LLC.*

FDA Label Image

Diphenoxylate 90ct Rls.107.90 1.0 Rev 05 22

This text provides information about Diphenoxylate Hydrochloride and Atropine Sulfate Tablets, USP, which should be stored below 25°C and dispensed in a well-closed, light-resistant, child-resistant container. The tablets contain 2.5 mg of diphenoxylate hydrochloride USP and 0.025 mg of atropine sulfate USP, which may be habit-forming and are not recommended for children under 6 years of age. The NDC number is 75826-107-90 and the tablets are Rx only. The manufacturer is Winder Laboratories, LLC in Winder, GA 30680. The remaining part of the text contains non-English characters and unreadable text.*

FDA Label Image

Diphenoxylate Winderlabs Logo

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.